Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways (2010)
- Authors:
- USP affiliated authors: MALPARTIDA, HUMBERTO MIGUEL GARAY - EACH ; SOGAYAR, MARI CLEIDE - IQ
- Unidades: EACH; IQ
- DOI: 10.1007/s10549-009-0362-9
- Subjects: APOPTOSE; NEOPLASIAS MAMÁRIAS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Breast Cancer Research and Treatment
- ISSN: 0167-6806
- Volume/Número/Paginação/Ano: v. 119, n. 3, p. 559-574, 2010
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
BUCHANAN, c et al. Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways. Breast Cancer Research and Treatment, v. 119, n. 3, p. 559-574, 2010Tradução . . Disponível em: https://doi.org/10.1007/s10549-009-0362-9. Acesso em: 09 maio 2024. -
APA
Buchanan, c, Stigliano, I., Garay-Malpartida, H. M., Gomes, L. R., Puricelli, L., Sogayar, M. C., et al. (2010). Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways. Breast Cancer Research and Treatment, 119( 3), 559-574. doi:10.1007/s10549-009-0362-9 -
NLM
Buchanan c, Stigliano I, Garay-Malpartida HM, Gomes LR, Puricelli L, Sogayar MC, Joffé EB de K, Peters MG. Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways [Internet]. Breast Cancer Research and Treatment. 2010 ; 119( 3): 559-574.[citado 2024 maio 09 ] Available from: https://doi.org/10.1007/s10549-009-0362-9 -
Vancouver
Buchanan c, Stigliano I, Garay-Malpartida HM, Gomes LR, Puricelli L, Sogayar MC, Joffé EB de K, Peters MG. Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways [Internet]. Breast Cancer Research and Treatment. 2010 ; 119( 3): 559-574.[citado 2024 maio 09 ] Available from: https://doi.org/10.1007/s10549-009-0362-9 - Recombinant human prolactin (rhPRL) promotes human beta cell survival by inhibiting apoptosis
- Recombinant human prolactin (rhPRL) promotes human beta-cell survival through apoptosis inhibition
- The novel cytoline PANDER/FAM3B inhibits cell death in prostate tumor cells
- The novel cytokine PANDER/FAM3B inhibits cell death in prostate tumor cells
- Recombinant human prolactin (rhPRL) promotes human beta-cell surviral by inhibiting apoptosis
- Modeling nonlinear gene regulatory networks from time series gene expression data
- Aminoacetone impairs prodution of insulin by RINm5f cells
- NUCEL (Cell and Molecular Therapy Center): a multidisciplinary center for translational research in Brazil
- Recombinant human prolactin promotes human beta cell survival via inhibition of extrinsic and intrinsic apoptosis pathways
- Toll-like receptor 4 (TLR4) expression in human and murine pancreatic beta-cells affects cell viability and insulin homeostasis
Informações sobre o DOI: 10.1007/s10549-009-0362-9 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
